share_log

Is Cognex Corporation (NASDAQ:CGNX) Potentially Undervalued?

Is Cognex Corporation (NASDAQ:CGNX) Potentially Undervalued?

康耐視公司(納斯達克股票代碼:CGNX)的估值可能被低估嗎?
Simply Wall St ·  04/26 22:32

Cognex Corporation (NASDAQ:CGNX), is not the largest company out there, but it saw a decent share price growth of 13% on the NASDAQGS over the last few months. Shareholders may appreciate the recent price jump, but the company still has a way to go before reaching its yearly highs again. As a mid-cap stock with high coverage by analysts, you could assume any recent changes in the company's outlook is already priced into the stock. However, could the stock still be trading at a relatively cheap price? Today we will analyse the most recent data on Cognex's outlook and valuation to see if the opportunity still exists.

康耐視公司(納斯達克股票代碼:CGNX)並不是目前最大的公司,但在過去的幾個月中,它在納斯達克證券交易所的股價上漲了13%。股東們可能會對最近的價格上漲表示讚賞,但該公司在再次達到年度高點之前還有很長的路要走。作爲分析師報道率高的中型股票,你可以假設該公司前景的任何最近變化都已計入該股。但是,該股票還能以相對便宜的價格交易嗎?今天,我們將分析有關康耐視前景和估值的最新數據,看看機會是否仍然存在。

What's The Opportunity In Cognex?

康耐視的機會是什麼?

According to our valuation model, Cognex seems to be fairly priced at around 8.55% above our intrinsic value, which means if you buy Cognex today, you'd be paying a relatively fair price for it. And if you believe that the stock is really worth $36.66, there's only an insignificant downside when the price falls to its real value. Is there another opportunity to buy low in the future? Since Cognex's share price is quite volatile, we could potentially see it sink lower (or rise higher) in the future, giving us another chance to buy. This is based on its high beta, which is a good indicator for how much the stock moves relative to the rest of the market.

根據我們的估值模型,康耐視的定價似乎比我們的內在價值高出約8.55%,這意味着如果您今天收購康耐視,您將爲此支付相對合理的價格。而且,如果你認爲這隻股票的真正價值36.66美元,那麼當價格跌至實際價值時,只有微不足道的下行空間。未來還有其他低價買入的機會嗎?由於康耐視的股價波動很大,未來我們可能會看到其下跌(或上漲),這爲我們提供了另一次買入機會。這是基於其較高的貝塔值,這是一個很好的指標,可以很好地衡量股票相對於其他市場的波動幅度。

Can we expect growth from Cognex?

我們可以期待康耐視的增長嗎?

earnings-and-revenue-growth
NasdaqGS:CGNX Earnings and Revenue Growth April 26th 2024
納斯達克股票代碼:CGNX 收益和收入增長 2024 年 4 月 26 日

Investors looking for growth in their portfolio may want to consider the prospects of a company before buying its shares. Although value investors would argue that it's the intrinsic value relative to the price that matter the most, a more compelling investment thesis would be high growth potential at a cheap price. With profit expected to more than double over the next couple of years, the future seems bright for Cognex. It looks like higher cash flow is on the cards for the stock, which should feed into a higher share valuation.

尋求投資組合增長的投資者可能需要在購買公司股票之前考慮公司的前景。儘管價值投資者會爭辯說,最重要的是相對於價格的內在價值,但更有說服力的投資論點是以低廉的價格獲得高增長潛力。預計未來幾年利潤將增加一倍以上,康耐視的前景似乎一片光明。看來該股的現金流即將增加,這應該會促進更高的股票估值。

What This Means For You

這對你意味着什麼

Are you a shareholder? It seems like the market has already priced in CGNX's positive outlook, with shares trading around its fair value. However, there are also other important factors which we haven't considered today, such as the track record of its management team. Have these factors changed since the last time you looked at the stock? Will you have enough conviction to buy should the price fluctuates below the true value?

你是股東嗎?看來市場已經對CGNX的樂觀前景進行了定價,股票的交易價格接近其公允價值。但是,我們今天還沒有考慮其他重要因素,例如其管理團隊的往績。自從你上次查看股票以來,這些因素是否發生了變化?如果價格波動低於真實價值,您是否有足夠的信心買入?

Are you a potential investor? If you've been keeping an eye on CGNX, now may not be the most advantageous time to buy, given it is trading around its fair value. However, the optimistic prospect is encouraging for the company, which means it's worth diving deeper into other factors such as the strength of its balance sheet, in order to take advantage of the next price drop.

你是潛在的投資者嗎?如果您一直在關注CGNX,那麼鑑於CGNX的交易價格接近其公允價值,現在可能不是最有利的買入時機。但是,樂觀的前景令該公司感到鼓舞,這意味着值得深入研究其他因素,例如資產負債表的強度,以便利用下一次價格下跌的機會。

In light of this, if you'd like to do more analysis on the company, it's vital to be informed of the risks involved. While conducting our analysis, we found that Cognex has 1 warning sign and it would be unwise to ignore it.

有鑑於此,如果你想對公司進行更多分析,了解所涉及的風險至關重要。在進行分析時,我們發現康耐視有 1 個警告信號,忽略它是不明智的。

If you are no longer interested in Cognex, you can use our free platform to see our list of over 50 other stocks with a high growth potential.

如果您不再對康耐視感興趣,您可以使用我們的免費平台查看我們列出的其他50多隻具有高增長潛力的股票清單。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論